Table 1 . Prenatal and postnatal fetal as well as maternal phenotypic characteristics and clinical outcome for two cases described here, and other published cases with corresponding identical variants in RIT1 gene.
+ – the characteristic was present, no – the characteristic was not present, an empty square – no information, GA – gestational age in weeks, CS – caesarian section, NP – not permitted/not performed, * – duplication of renal collection system, ¥ – hyperechogenic left kidney, § – Dandy-Walker malformation, $ – cFTR not performed, 1st scan at GA 21, ¤ – severe at GA 25, p – superior vena cava, atrial septal defect, bilateral talipes.
If GA or other information about the fetal demise is not written, it is unknown or not provided by the authors.
REFERENCES
1. Roberts, A.E., et al., Noonan syndrome. Lancet, 2013.381 (9863): p. 333-42.
2. Cai, J. and H. Li, A novel RIT1 mutation causes deterioration of Noonan syndrome-associated cardiac hypertrophy. EBioMedicine, 2019.42 : p. 6-7.
3. Cave, H., et al., Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia. Eur J Hum Genet, 2016. 24 (8): p. 1124-31.
4. Aoki, Y., et al., Recent advances in RASopathies. J Hum Genet, 2016. 61 (1): p. 33-9.
5. Milosavljevic, D., et al., Two cases of RIT1 associated Noonan syndrome: Further delineation of the clinical phenotype and review of the literature. Am J Med Genet A, 2016. 170 (7): p. 1874-80.
6. Calcagni, G., et al., Congenital heart defects in Noonan syndrome and RIT1 mutation. Genet Med, 2016. 18 (12): p. 1320.
7. Yaoita, M., et al., Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations. Hum Genet, 2016. 135 (2): p. 209-22.
8. Bertola, D.R., et al., Further evidence of the importance of RIT1 in Noonan syndrome. Am J Med Genet A, 2014. 164A (11): p. 2952-7.
9. Yates, C.L., et al., Whole-exome sequencing on deceased fetuses with ultrasound anomalies: expanding our knowledge of genetic disease during fetal development. Genet Med, 2017. 19 (10): p. 1171-1178.
10. Hadlock, F.P., et al., Estimation of fetal weight with the use of head, body, and femur measurements–a prospective study. Am J Obstet Gynecol, 1985. 151 (3): p. 333-7.
11. Aoki, Y., et al., Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. Am J Hum Genet, 2013.93 (1): p. 173-80.
12. Gos, M., et al., Contribution of RIT1 mutations to the pathogenesis of Noonan syndrome: four new cases and further evidence of heterogeneity. Am J Med Genet A, 2014. 164A (9): p. 2310-6.
13. Kouz, K., et al., Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation. Genet Med, 2016. 18 (12): p. 1226-1234.
14. Sparks, T.N., et al., Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis. N Engl J Med, 2020. 383 (18): p. 1746-1756.